Deadly Species of Mosquito: New Species of Mosquito more Harmful than Anopheles has been Confirmed.
Deadly Species of Mosquito: The invasion of a new species of mosquito that is more harmful than the anopheles has been confirmed by the Ghana Health Service (GHS).
Deadly Species of Mosquito: According to the World Health Organization, the new breed known as Anopheles Stephensi is likewise a malaria-transmitting mosquito, extremely invasive, spreads faster, and can adapt to a variety of climatic circumstances.
Residents in Tuba and Dansoman have been cautioned to take precautions after GHS established a foothold there.
Deadly Species of Mosquito: Anopheles Stephensi first entered Africa in 2019, invading Ethiopia, Sudan, Somalia, Nigeria, and, regrettably, Ghana just this past March.
Both P Vivax malaria parasites and Plasmodium Falciparum, the most deadly form of plasmodium that causes malaria, are produced by this breed.
Also, the World Health Organization’s most recent mathematical modelling study demonstrated the expansion of An. stephensi and its implications for the transmission and management of malaria in Africa.
Deadly Species of Mosquito: According to one research, if An. stephensi spreads unchecked, and 126 million more individuals in Africa might be in danger of contracting malaria.
Also check: New Approved Malaria Vaccine: Ghana is the First Country to Approve the Malaria Vaccine.
The statement also discloses that this breed is extremely challenging to manage since it is resistant to a variety of pesticides. Currently, it is unknown what may actually kill it.
To reduce the number of breeding grounds, the GHS has established a taskforce to execute a variety of initiatives, such as removing water collection points from within and around residences and communities.
Another method that has been suggested to increase prevention is to avoid mosquito bites by utilising mosquito nets sprayed with pesticide.
As part of efforts to fight the illness, Ghana became the first nation in Africa to approve a novel malaria vaccine developed by Oxford University.
The World Health Organization last year recommended the British pharmaceutical company GSK’s MOSQUIRIX.
Credit: Ghana Health Service